Free Trial
LON:MXCT

MaxCyte (MXCT) Share Price, News & Analysis

MaxCyte logo
GBX 168.50 +3.00 (+1.81%)
As of 03:38 AM Eastern

About MaxCyte Stock (LON:MXCT)

Key Stats

Today's Range
168.50
170
50-Day Range
161.15
241
52-Week Range
160
407.84
Volume
9,803 shs
Average Volume
42,240 shs
Market Capitalization
£222.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions. Let’s Build Better Cells Together. To learn more, please visit www.maxcyte.com

Receive MXCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter.

MXCT Stock News Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
6MXCT : A Look at MaxCyte's Upcoming...
MaxCyte to Propose AIM Delisting to Shareholders
MaxCyte (MXCT) Gets a Buy from BTIG
See More Headlines

MXCT Stock Analysis - Frequently Asked Questions

MaxCyte's stock was trading at GBX 321.20 at the beginning of the year. Since then, MXCT stock has decreased by 48.6% and is now trading at GBX 165.
View the best growth stocks for 2025 here
.

Shares of MXCT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that MaxCyte investors own include HSBC (HSBA), Royal Dutch Shell (RDSB), Cassava Sciences (SAVA), EQTEC (EQT), Grafton Group (GFTU), Lloyds Banking Group (LLOY) and Marks and Spencer Group (MKS).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
Business Services
Current Symbol
LON:MXCT
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£45.08 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£57.52 million
Cash Flow
GBX 83.67 per share
Price / Cash Flow
1.97
Book Value
GBX 203.85 per share
Price / Book
0.81

Miscellaneous

Free Float
N/A
Market Cap
£217.81 million
Optionable
Not Optionable
Beta
1.13
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (LON:MXCT) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners